This episode dives into emerging research regarding probiotics specifically tailored to treat psoriasis and possibly other inflammatory skin diseases.
AbbVie Unveils Promising 148-Week VALUE Trial Data for Risankizumab at IFPA Conference
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Discovering Dermatology Times: June 2024 Print
PODCAST: From Infection to Innovation - The Turn Therapeutics Story
Validation of Improved QoL Assessment for Moderate Psoriasis
Interview Intersection: Expert Interviews From June 2024